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AgingHomologous recombination (HR)-mediated instability of the repetitively organized ribosomal DNA (rDNA) has
been proposed as amediator of cell senescence in yeast triggering the DNA damage response. High individual var-
iability in the content of human rDNA suggests that this genomic region remained relatively unstable throughout
evolution. Therefore, quantitative real-time polymerase chain reactionwas used todetermine the genomic content
of rDNA in post mortem samples of parietal cortex from 14 young and 9 elderly individuals with no diagnosis of a
chronic neurodegenerative/neurological disease. In addition, rDNA content in that brain region was compared be-
tween 10 age-matched control individuals and 10 patients with dementia with Lewy bodies (DLB) which involves
neurodegeneration of the cerebral cortex. Probing rRNA-coding regions of rDNA revealed no effects of aging on the
rDNA content. Elevated rDNA content was observed in DLB. Conversely, in the DLB pathology-free cerebellum,
lower genomic content of rDNA was present in the DLB group. In the parietal cortex, such a DLB-associated insta-
bility of rDNA was not accompanied by any major changes of cytosine–phosphate–guanine methylation of the
rDNA promoter. As increased cerebro-cortical rDNA content was previously reported in Alzheimer's disease, neu-
rodegeneration appears to be associated with instability of rDNA. The hypothetical origins and consequences of
this phenomenon are discussed including possibilities that the DNA damage-induced recombination destabilizes
rDNA and that differential content of rDNA affects heterochromatin formation, gene expression and/or DNA dam-
age response. This article is part of a Special Issue entitled: Role of the Nucleolus in Human Disease.
© 2014 Elsevier B.V. All rights reserved.1. Introduction
Aging-associated disorders including proliferative senescence,
cancer and neurodegeneration have been proposed to originate from
accumulation of DNA damage leading to genomic instability [1,2].
Thus, loss of telomeres, aswell as de-regulated homologous recombina-
tion (HR) have been associated with aging and/or aging-related disor-
ders [2,3]. Telomere shortening that in proliferating cells triggers DNA
damage response and cell cycle arrest has been observed in leukocytes
from patients with Alzheimer's disease (AD) and dementia with Lewy
bodies (DLB) [4–6]. In these conditions, dementia is believed toe; CpG, cytosine–phosphate–
amage response; HR, homol-
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man).
ights reserved.originate from degenerative changes in the hippocampus and/or the
cerebral cortex. In AD, telomere shortening may have complex effects
including neuroprotective reduction of inﬂammation but also increased
neuronal dysfunction [7]. While the role of HRmalfunction in prolifera-
tive senescence or cancer is well established [2,3], its contribution to
neurodegeneration is unclear.
The ribosome is a critical component of translation machinery.
Hence, complex mechanisms evolved to adjust ribosomal production
to cellular needs. For instance, in Eukaryotes, genes that encode rRNA,
the key component of ribosomeswere ampliﬁed [8–10]. Such ampliﬁca-
tion resulted in approximately 300 copies of nucleolar 47S rRNA genes
(rDNA) per haploid human genome. These genes are organized in ﬁve
clusters of tandem repeats on short arms of acrocentric chromosomes
13, 14, 15, 21 and 22. It is believed that the primary force driving
rDNA ampliﬁcation was a need to produce large number of ribosomes
during periods of rapid proliferative growth. However, under normal
growth conditions, only about half of rDNA units participate in ribosom-
al biogenesis while the other half remains transcriptionally inactive and
epigenetically silenced [8]. Hence, possessingmultiple inactive copies of
rRNA genesmay have enabled cells to tolerate loss of some of the active
copies of these critical genes. Finally, rDNA acquired additional
functions regulating chromatin structure, gene expression and stress
861J. Hallgren et al. / Biochimica et Biophysica Acta 1842 (2014) 860–868response [11–14]. These activities do not appear to be directly related to
ribosomal biogenesis.
Repetitive nature of rDNA poses a challenge for genome mainte-
nance. HR of rDNA units within one cluster or between clusters that
are located on different chromosomes may lead to genomic instability
including loss of rDNA, its ampliﬁcation and chromosomal transloca-
tions [3,15]. In 1972, Bernard Strehler proposed a hypothesis that
aging-related loss of rDNA in post-mitotic cells, including muscles and
neurons, leads to aging associated dysfunction simply by insufﬁcient
ribosome supply and translational failure [16]. However, subsequent
studies including those in post mortem samples of the human cerebral
cortex did not conﬁrm early observations of aging-associated changes
in the genomic rDNA content [17,18]. Likewise, no disruption of rDNA
stability has been found in cell culture models of replicative senescence
[19,20].
However, the negative reports on effects of aging on rDNA copy
number in vertebrates used hybridization methods that did not allow
for a detailed, high resolution insight into stability of this region. Each
human rDNA unit is 43 kb long and contains the 34 kb-long intergenic
spacer and the 47S pre-rRNA gene including a promoter and exons that
correspond to 18S, 5.8S, and 28S rRNAs [8] (Fig. 1). Indeed, more recent
work that employed qPCR technique to selectively probe the 18S, 5.8S
and 28S rRNA-coding portions of rDNA suggested age-dependent
decrease of rDNA content in human adipose tissue that was limited
to 5.8S and 28Ss regions [21]. However, in this study, the age effects
were modest despite investigating a relatively large population
(n = 120). Conversely, the in situ hybridization-based approach of
molecular combing revealed that in cells derived from normal individ-
uals about 30% of rDNA units are organized as palindromic rather than
as tandem repeats [22]. In cells fromWS cases, frequency of such non-
canonical repeats increased to 50%. Moreover, high dynamics of
human rDNA is suggested by high individual variability in length of
the entire rDNA clusters as revealed by pulsed ﬁeld gel electrophoresis
studies [23]. Such an effect was attributed to a high rate of meiotic
rDNA recombinationwhichwas estimated to be at least 10% permeiosis
per each cluster. Mitotic rDNA recombination was also detected in
normal individuals. Interestingly, increased mitotic instability of rDNA
has been found in at least 50% of human colon or lung cancer samples
[24]. Finally, genomic instability disorders including ataxia telangiecta-
sia and Bloom syndrome have been linked to very high rates of mitotic
rDNA cluster length instability [25]. Hence, in higher Eukaryotes includ-
ing humans, rDNA is unstable. However, the role of human rDNA insta-
bility in aging or aging-associated diseases remains unresolved.
In contrast, there is strong evidence that replicative senescence in
yeast is caused by rDNA instability [26,27]. DNA damage is presumed
to trigger such instability. Initially, it has been proposed that the pro-
senescence effector of rDNA instability in yeast was accumulation of a
toxic byproduct of rDNA HR, the extrachromosomal rDNA circles [28].
However, current data better ﬁt to a model in which rDNA loss by itself
triggers senescence by activating the DNA damage response (DDR) in aPromoter
rDNArDNArDNA rDNA rDNA
+1
18S 28S
5.8S
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Fig. 1. The qPCR-based assay to determine the genomic content of rDNA. The rDNA copies ar
consists of the rRNA gene and the intergenic spacer (IGS). Each rRNA gene includes a Pol1-depe
by introns (5′ETS, ITS1, ITS2 and 3′ETS). The positions of the analyzed rDNA amplicons are indribosomal biogenesis-independent manner [13,29]. Such a model
implies that the extra rDNA copies that are not active in ribosome
production are required to suppress the DDR [26]. Thus, Kobayashi has
proposed that rDNA copy number could work as a sensor of environ-
mental exposures to genotoxic agents complementing the genome
integrity sensing function of telomeres which measure the number of
cell divisions [26]. However, it remains to be tested whether rDNA
content affects DDR in higher Eukaryotes.
In yeast, HR underlies rDNA instability including rDNA loss and
rDNA expansion [15,30]. These mechanisms operate during DNA repli-
cation and involve unequal sister chromatid exchange. The rDNA loss
and expansion appear to balance each other in non-senescent yeast
cells [26]. Likewise, HR appears to play an important role in human
rDNA stability as the excessive HR in cells from Bloom syndrome
patients is associatedwith a pronounced increase inmitotic rDNA insta-
bility [25]. In yeast and mouse cells, maintaining a pool of inactive,
epigenetically silenced copies of rDNA is critical for rDNA stability
[26,31].
Previously we have used qPCR to demonstrate increased genomic
content of 18S rDNA region in the parietal cortex of Alzheimer's disease
(AD) patients [32]. Moreover, the increased copy number was associat-
ed with an increase in rDNA promotermethylation which is a signature
of epigenetic silencing of rDNA. Hence, a question could be raised
whether in the brain, aging involves segmental instability of rDNA
that is prevented by the AD-associated epigenetic silencing of rDNA.
Alternatively, rDNA instability including its ampliﬁcationmay be associ-
ated with neurodegeneration. To address these possibilities, we have
compared rDNA content in the parietal cortex from young and old indi-
viduals. In addition, we have determined rDNA content and its methyl-
ation in the cerebral cortex and the cerebellum of DLB patients.
2. Methods
2.1. Subjects and sample preparation
For aging studies fresh ﬂash-frozen samples of parietal cortex
(Brodmann areas 39 and 40) were obtained from the NICHD Brain and
Tissue Bank for Developmental Disorders at the University of Maryland,
Baltimore,MD. The young donor group consisted of 7men and7women
(1–25 years old, median age: 20); the old donor group consisted of 4
men and 5 women (73–90 years old, median age: 79). The donors had
no prior history of a chronic neurodegenerative or neurological disease.
The post mortem intervals (PMIs) were comparable for both groups
averaging 7.5 h (PMIs were always less than 14 h). For DLB studies,
the donors were participants of the IRB-approved University of Ken-
tucky Alzheimer's Disease Center cohort and were followed for at least
2 years before death [33]. The follow-up included annual Minimental
State Examination (MMSE) as well as neurological and physical exami-
nations. The donors had no history of substance abuse, head injury,
encephalitis, meningitis, epilepsy, or stroke/transient ischemic attack.Intergenic Spacer
rDNA rDNArDNA rDNA
TS
rDNA
e organized as long tandem repeats located on ﬁve acrocentric chromosomes. Each copy
ndent promoter and exons that correspond to 18S, 5.8S and 28S rRNAs. They are separated
icated by the thick black lines. The schematics are not drawn in scale.
Table 2
Control and DLB donors of the parietal cortex and the cerebellum samples that were used
for the DLB studies.
Group Age (years) PMI (h)a Sex Parietal cortex Cerebellum
Control 77 3.5 Male + Unavailable
81 2 Male + Unavailable
87 2.4 Male + Unavailable
82 2.1 Male + Unavailable
862 J. Hallgren et al. / Biochimica et Biophysica Acta 1842 (2014) 860–868TheMMSE score closest to deathwas used as an indicator of overall cog-
nitive status. During autopsy (usually 5 or less hours after death), tissue
samples including parietal cortex and cerebellum were processed for
neuropathological evaluations or ﬂash-frozen in liquid nitrogen and
stored at −80 °C, as described previously [33,34]. All included DLB
subjects met the clinical and histopathological criteria for diagnosis of
DLB [35]. The control subjects received MMSE scores ≥ 23 with Braak
staging at≤2. Detailed donor information is presented in Tables 1 and 2.85 2.5 Female + +
90 2 Female + +
79 1.8 Female + +
78 1.2 Male + +
81 2.8 Male + +
96 2.1 Female + +
86 2.5 Female Not included +
90 3.8 Female Not included +
80 2.5 Female Not included +
95 2.8 Female Not included +
DLB 78 2.5 Male + +
78 3.8 Male + +
81 2.5 Male + +
72 2.8 Male + +
65 9.5 Male + +
87 2 Female + +
68 3.8 Male + +
90 2.5 Female + +
82 2.3 Male + +
91 10.5 Female + +
a PMI, post mortem interval.2.2. Analysis of genomic rDNA content
Genomic qPCR using standard curve based analysis was utilized to
determine rDNA content. Amplicons targeting 18S, 5.8S, and the 28S
coding regions of rDNAwere used (Fig. 1). For normalization, amplicons
corresponding to the coding regions of the tRNAK-ctt gene or the albumin
gene (ALB) were ampliﬁed. Primer sequences were as follows, 18S
forward agcctgagaaacggctacca and reverse ggtcgggagtgggtaat
ttgc, 5.8S forward gaggcaaccccctctcctctt and reverse gagccga
gtgatccaccgcta, 28S forward gacctcagatcagaggtggcga and
reverse ttcactcgccgttactgagggaat, tRNAK-ctt forward ctagctca
gtcggtagagcatg and reverse ccaacgtggggctcgaac, and ALB
forwardcggcggcgggcggcgcgggctgggcggaaatgctgcacagaatccttg
and reverse gcccggcccgccgcgcccgtcccgccggaaaagcatggtcgcc
tgtt.2.3. Bisulﬁte mapping of rDNA promoter methylation
Bisulﬁte mapping of rDNA promoter methylation was performed as
described previously [32]. Brieﬂy, two hundred ng of DNA/sample was
treated with bisulﬁte to convert unmethylated cytosines to uracil. The
rDNA promoter region was PCR-ampliﬁed and cloned into the pGEM-
T vector. Following bacterial transformation, individual cloneswere iso-
lated and sequenced. Only clones with unique methylation patterns
were included in the analysis to avoid potential PCR/cloning artifacts.
Clones with incomplete bisulfate conversion were also discarded.
Thus, twenty fully converted, and unique clones were analyzed for
each individual.Table 1
Young and old donors of the parietal cortex samples that were used for the aging studies.
Group Age (years) PMI (h)a Sex
Young 2 10 Male
15 9 Female
16 7 Male
18 8 Female
19 7 Female
20 6 Male
20 5 Male
21 7 Male
22 10 Female
22 7 Male
24 9 Female
24 7 Female
24 9 Male
25 4 Female
Old 73 13 Female
76 3 Female
76 3 Male
77 8 Female
79 5 Male
79 10 Male
88 8 Female
89 14 Male
90 4 Female
a PMI, post mortem interval.2.4. DNA methylation analysis using the methyl-CpG sensitive restriction
enzyme HpaII
Methylation of the HpaII site located at position−9 relative to the
transcription start site (CpG #23 of the human rDNA promoter)was an-
alyzed with quantitative real-time PCR of the HpaII-digested genomic
DNA as described previously [32] with modiﬁcations. Importantly, as a
reference, the HpaII-digested DNA was used as template to determine
the content of an amplicon adjacent to the one with the HpaII site.
Such a normalization resulted in reproduciblemethylation values as op-
posed to using a non-digested DNA with the HpaII amplicon. QPCR
primer sequences were as follows: HpaII forward: gtatatcttt
cgctccgagtcg; HpaII reverse: acaggtcgccagaggacag; reference
forward: acggacgttcgtggcga; reference reverse: ggagaggaga
gacgagggg.2.5. Evaluation of methylation effects on qPCR efﬁciency
An unmethylated DNA template for the 5.8S amplicon was obtained
by PCR on genomic DNA (primer sequences: forward cccgtggtgt
gaaacctt, reverse agctagctgcgttcttcatc). The PCR product was
then in vitromethylated in a buffer containing 6 ng DNA/μL, 0.16 mM
S-adenosylmethionine and 0.2 unit M.SssI/μL (New England Biolabs)
at 37 °C for 2 h followed by M.SssI inactivation at 65 °C for 20 min.
Methylated and unmethylated templates were used for qPCR with the
5.8S amplicon primers. To verify the extent of methylation, both meth-
ylated and unmethylated templates were incubated with the methyl
sensitive restriction enzymeHpaII. Template resistance toHpaII was de-
termined by qPCR.2.6. Statistical analysis
Statistical analysis was performed using the non-parametric
Kruskal–Wallis one way ANOVA and linear regression ﬁtting. In addi-
tion, comparisons of individual rDNA methylation sites were accom-
plished using a modiﬁed signiﬁcance analysis of microarrays (SAM),
as reported previously [32].
0.50
0.75
1.00
1.25
1.50
1.75
2.00
0.50 0.75 1.00 1.25 1.50 1.75 2.00
y = 0.7327x + 0.2755
R² = 0.8103
18s Gene Content
28
s 
G
en
e 
Co
nt
en
t
0
0.2
0.4
0.6
0.8
1.0
1.2
1.4
1.6
1.8
YOUNG OLD
18
s 
rD
NA
 C
on
te
nt
18
s 
rD
NA
 C
on
te
nt
Reference Gene: tRNA-KCTT
Reference Gene: ALB
A
B
0
0.2
0.4
0.6
0.8
1.0
1.2
1.4
1.6
1.8
YOUNG OLD
28
s 
rD
NA
 C
on
te
nt
Reference Gene: tRNA-KCTT
C
D
p>0.05p>0.05
p>0.05
0
0.2
0.4
0.6
0.8
1
1.2
1.4
1.6
1.8
YOUNG OLD
Fig. 2. Effects of age on the cerebro-cortical content of rDNA. Genomic rDNA content
was quantiﬁed in post mortem samples of the parietal cortex from young and old
individuals without any neurodegenerative conditions (n = 14, median age 20,
and n = 9, median age 79, respectively). The 18S and 28S amplicons were used for
rDNA content determinations; the reference genes are indicated. For each amplicon,
the rDNA content was normalized to average value of young individuals. A, Regres-
sion analysis of individual values of rDNA content as determined with 18S or 28S
probes. As expected for a close physical linkage between these genomic templates,
a direct correlation is present supporting validity of the qPCR assay. Filled or opened
diamonds indicate young or old individuals, respectively. B–D, Content of rDNA is
similar in young and old individuals. Individual values are depicted by squares;
mean values are indicated by the lines intersecting the error bars (SEM); p values
of the Kruskal–Wallis ANOVA are shown.
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3.1. Stability of the cerebro-cortical rDNA copy number in aging
To assess the effects of aging on rDNA copy number in the brain,
genomic DNA was isolated from post mortem parietal cortex samples
that were collected from two groups of donors. The young donor
group consisted of 14 individuals with a median age of 20 ± 1.6
(range 1–25, Table 1). The old donor group included 9 individuals
with a median age of 79 ± 2.1 (range 73–90, Table 1). None of the
donors were known to suffer from a chronic neurodegenerative and/
or neurological disease. The genomic content of 18S and 28S rRNA
coding regions of rDNA was analyzed by a qPCR assay (Fig. 1). For
normalization, a coding region of the multi-copy gene tRNAK-ctt was
used. There are 17 almost identical copies of this gene in the haploid
human genome. However, in contrast to rDNA, they are not clustered
together [36] and therefore, are less likely than rDNA to undergo
recombination-associated instability.
As the investigated rDNA regions are physically linked, a direct
correlation between their genomic content for each analyzed sample
is expected (Fig. 1). Indeed, the individual values obtained for the 18S
and the 28S amplicons were strongly correlated ﬁtting to a linear
model of a direct correlation (Fig. 2A, a = 0.7327, R2 = 0.8103).
These results support accuracy of the applied qPCR methodology for
determination of the genomic rDNA content.
However, genomic content of 18S and 28S regions of rDNA did not
signiﬁcantly differ between the young and the old subjects (Fig. 2B, C).
Usage of a coding region of the albumin gene (ALB) as an alternative
genomic reference produced similar results (Fig. 2D). Therefore, in the
cerebral cortex, genomic content of rDNA appears to be stable through-
out the lifespan.
3.2. DLB-associated instability of brain rDNA
To assess whether aging-related neurodegeneration affects genomic
rDNA content in the brain, post mortem parietal cortex samples from ten
patients who were diagnosed with DLB were analyzed (Table 2). The
control group included ten age-matched individuals who died of non-
neurological diseases and whose brains did not display any evidence
of neurodegeneration (Table 2). Similar to the midbrain-focused
Parkinson's disease (PD), DLB is a form of a synucleinopathy [37,38].
Their common characteristic is the presence of intracytoplasmic α-
synuclein-containing inclusions, the Lewy bodies. In addition, DLB is
associated with neuronal atrophy, neuronal death and reactive gliosis
in the cerebral cortex including the parietal region [37]. Oxidative
damage of macromolecules including DNA is observed in both condi-
tions [39,40]. Hence, DLB and PD may represent a similar pathological
process that affects different areas of the brain.
Three rDNA coding regions were analyzed including probes corre-
sponding to the 18S, 5.8S, and 28S exons. As expected for a tight physi-
cal linkage, the DLB- and the control group-derived individual values
obtained with these probes correlated with each other ﬁtting a linear
model of direct correlation (28S(18S), y = 1.7416 ∗ x − 0.6165,
R2 = 0.8495; 5.8S(18S), y = 1.4776 ∗ x − 0.4126, R2 = 0.8957;
28S(5.8S), y = 1.1008 ∗ x − 0.0133, R2 = 0.8274). Interestingly,
genomic content of rDNA was higher in DLB. In this group, the 18S,
5.8S, and 28S probes revealed rDNA content that was 1.6-, 2.0-, and
2.3-fold controls respectively (Kruskal–Wallis ANOVA, p b 0.01,
Fig. 3A–C). Similar resultswere obtainedwhen ALBwasused as an alter-
native genomic reference (Fig. 3D). To determine whether this DLB-
associated effect on rDNA content was directly related to pathological
changes in the cortex, samples from the DLB pathology-free cerebellum
were analyzed. In samples from this structure, direct correlations
between individual values for various rDNA probes were observed
conﬁrming accuracy of our determinations (data not shown). Surpris-
ingly, in the cerebellum, rDNA content was lower in the DLB group.Signiﬁcant decreases of 0.55- and 0.42-fold controls were observed for
the 5.8S and 28S probes, respectively (Kruskal–Wallis ANOVA,
p b 0.01, Fig. 4). While the 18S probe did not detect signiﬁcant differ-
ences between the two groups, the genomic 18S content also showed
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Fig. 3. Increased rDNA content in the DLB parietal cortex. Genomic rDNA content was
quantiﬁed in post mortem samples of the parietal cortex from DLB and age-matched
control individuals without any neurodegenerative conditions (n = 10 each). The 18S,
5.8S and 28S ampliconswere used for the determinations; the reference genes are indicat-
ed. Regression analysis of individual values for pairs of rDNA amplicons revealed strong
correlations similar to those in Fig. 2A (see the Results section for more details). In the
DLB group, signiﬁcant increases of rDNA content were detected using the 18S/tRNAK-ctt
(A), 5.8S/tRNAK-ctt (B), 28S/tRNAK-ctt (C) and 18S/ALB (D) ratios. Individual values are
depicted by squares; mean values are indicated by the lines intersecting the error bars
(SEM); p values of the Kruskal–Wallis ANOVA are shown.
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Fig. 4. Decreased rDNA content in the DLB cerebellum. Genomic rDNA content was
quantiﬁed in post mortem samples of the cerebellum from 10 DLB and 10 aged-matched
control individuals. Regression analysis of individual values for pairs of rDNA amplicons
revealed strong correlations similar to those in Fig. 2A (data not shown). While a
downward trend was observed for the 18S amplicon (A), the 5.8S and the 28S probes
revealed signiﬁcant decreases of rDNA content in DLB samples (B–C). Individual values
are depicted by squares; mean values are indicated by the lines intersecting the error
bars (SEM); p values of the Kruskal–Wallis ANOVA are shown.
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associated with instability of brain rDNA.
3.3. Effects of DLB on methylation of the rDNA promoter region
At least in cancer cell lines, ampliﬁcation of rDNAmay be associated
with CpG hypermethylation [41]. As CpGmethylation of the rDNA is as-
sociated with epigenetic silencing of rDNA copies a combination of am-
pliﬁcation and hypermethylationmay help to keep the number of active
rDNA copies constant [8]. Moreover, epigenetic silencing of rDNA may
stabilize the inactive genes preventing recombination; conversely, de-
silencing may have an opposite effect [26,31]. Thus, methylation of the
rDNA promoter region was analyzed in the parietal cortex of the DLB
and control groups using the CpG methylation-sensitive restriction en-
donuclease HpaII or bisulﬁte sequencing. Methylation of the rDNA pro-
moterwas similar in theDLB and the control group (Fig. 5). Therefore, in
the DLB pathology-affected cerebral cortex, rDNA ampliﬁcation is not
associated with changes in CpG methylation of the rDNA promoter.
3.4. Effects of template methylation on qPCR efﬁciency
Methylation of rDNA is observed not only in the promoter region but
also in the rRNA-coding exons that have been targeted for qPCR-based
rDNA quantiﬁcation. Therefore a possibility exists that the apparent
DLB-associated changes in rDNA content are due to altered methyl-
CpG content in those regions if methylation affects qPCR ampliﬁcation
efﬁciency. To exclude such a possibility, non-methylated rDNA frag-
ment containing the 5.8S amplicon template was produced by PCR. As
the 5.8S amplicon contains 19 CpG sites including 3 in the reverseprimer target sequence methylated template was generated in vitro
using a non-selective CpG DNA methyltransferase M.SssI (Fig. 6). As
compared to the unmethylated template, methylation only slightly
increased qPCR efﬁciency resulting in about 10% overestimation of the
template content. Therefore, even dramatic changes in CpGmethylation
of the rDNA templates are unlikely to explain up to 130% increases or
decreases of rDNA content that were observed between control and
DLB samples.
4. Discussion
In this study, the qPCR-based analysis of the genomic rDNA content
in the cerebral cortex revealed nomajor differences between young and
old individuals. However, in DLB and age-matched control brains rDNA
content differed signiﬁcantly. Increased rDNA levels were observed in
the neurodegeneration-affected parietal cortex and decreased rDNA
levels were found in the DLB pathology-free cerebellum. Therefore,
rDNA instability in the brain appears to be associated with this form of
synucleinopathy. One might speculate that similar instability accom-
panies other synucleinopathies including PD.
In concert with our ﬁndings, no aging effects on rDNA content in the
human cerebral cortex were found using a hybridization approach [42].
Conversely, we have reported an apparent increase in the genomic
rDNA levels in the parietal and frontal cortices of individuals with
advanced AD or mild cognitive impairment (MCI), which often repre-
sents early stage AD [32]. In the cerebellum, rDNA content did not
seem to be affected by AD. As both the parietal and frontal cortices but
not the cerebellum display AD-related pathology including plaques,
tangles, neuronal atrophy, neuronal loss and reactive gliosis, the AD-
associated elevations of the cerebro-cortical rDNA content appear to
be associated with neurodegeneration. A similar conclusion applies to
5.8S rDNA Content
CpG HpaII Methylation
%
M
et
hy
la
tio
n
5.8S rDNA Content
(% Unmethylated)
0
20
40
60
80
100
120
0
20
40
60
80
100
120
MethylatedUnmethylated
In Vitro Methylation (M.SssI)
 rDNA Gene
Intergenic Spacer
Promoter
+1
18S 28S
5.8S
HpaII
HpaII
Methylated Template
Unmethylated Template
B
A
Fig. 6. Effects of template methylation on qPCR efﬁciency. A, PCR on genomic DNA was
used to produce an unmethylated DNA fragment including a template for the 5.8S qPCR
amplicon that revealed rDNA instability in DLB (red box, qPCR primers indicated by red
arrows, PCR primers indicated by black arrows). DNA was then in vitromethylated with
M.SssI DNA methyltransferase that indiscriminately targets all CpG sites. Note the
presence of multiple CpGs in the 5.8S amplicon (opened and ﬁlled circles correspond to
CpGs ormethyl-CpGs, respectively; one of the CpGs is part of an HpaII site). B, Methylation
of a CpG that was part of an HpaII site was conﬁrmed using HpaII-qPCR assay. When
methylated DNA fragment was used as a template for 5.8S qPCR, rDNA content was
overestimated by just 10% as compared to unmethylated template. Hence, differential
methylation of rDNA templates of the qPCR amplicons is unlikely to account for DLB-
associated changes in rDNA content. Data represent two independent experiments;
error bars are SDs.
0
20
40
60
80
DLB Control%
 rD
NA
 p
ro
m
ot
er
M
et
hy
la
tio
n
B
0
10
20
30
40
50
DLB Control
%
 M
et
hy
la
tio
n
Cp
G
 #
23
A
C
p>0.05
p>0.05
0
20
40
60
80
5 10 15 20 25
DLB Control
CpG Index
%
 M
et
hy
la
tio
n
*
*
Fig. 5. Similar methyl-cytosine content of the rDNA promoter region in the control and
DLB parietal cortex. A, Methylation of the rDNA promoter CpG#23 (position −9 from
the transcription start site) content was determined using a methylation-sensitive
enzyme HpaII and qPCR. B–C, Methylation of all 26 CpG sites within the human rDNA
promoter region (positions−186 to +26) was investigated using bisulfate sequencing.
B, Average CpG methylation in the rDNA promoter. C, Effect of DLB on distribution of
CpG methylation across the rDNA promoter. The data represent averages ± SEM from
10 DLB and 10 control individuals. Individual values are depicted by squares; mean
values are indicated by the lines intersecting the error bars. In A and B, p values of the
Kruskal–Wallis ANOVA are shown; in C, *, p b 0.05 (SAM statistics). Although CpG#7
and 17 appeared hypermethylated in DLB, the overall trend of CpG methylation across
the 26 rDNA promoter CpGs was not signiﬁcantly affected by DLB (local regression
analysis, data not shown).
865J. Hallgren et al. / Biochimica et Biophysica Acta 1842 (2014) 860–868the current study of DLB cases. However, unlike AD, DLB seems to be
associated with reduced rDNA content in the neurodegeneration-
free cerebellum. Thus, at least in DLB, rDNA becomes unstable in
neurodegeneration-affected and unaffected brain regions. In the
degenerating areas, the rDNA expansions would be the predominant
product of such a destabilization; in the non-degenerating areas, rDNA
instability would result in rDNA loss. While causes for such different
outcomes of rDNA instability are unclear, similar divergence has been
reported for another unstable region of the genome, the telomere.
Telomere shortening has been observed in the peripheral blood leuko-
cytes in AD, and DLB [4–6]. However, at least in AD, telomere expansion
has been reported in the AD pathology-affected hippocampus [4].
Although somatic rDNA instability appears to be the most probable
source of the observed differences between the DLB and the control
group one cannot formally exclude a possibility that in addition to
rDNA instability, our results are also affected by germ line-derived
rDNA copy number polymorphisms that are associated with an
increased risk of DLB.
HR has been identiﬁed as a major mechanism of rDNA instability
[15,26,30]. Hence, our current as well as previously published results
suggest that in DLB or AD HR becomes activated in the brain. As this
process is thought to occur during or after DNA replication peaking in
the S phase of the cell cycle [43,44], the observed rDNA instability may
be localized to reactive glia that underwent divisions in response
to neurodegeneration [45,46]. Alternatively, as neuronal cell cycle re-
entry has been documented in AD-affected brain regions, re-activation
of HR in normally post-mitotic neurons may also be possible [47–49].
Finally, as rDNA is present in 5 clusters on 5 distinct chromosomes
that all reside in close physical proximity within the nucleolus and the
nucleolus-associated heterochromatin, HR of rDNA may, at least
theoretically, occur in the absence of the replication-generated sister
chromatids. Such a “non-replicative” recombination could engage
homologous rDNA units within the same chromatid or from differentchromosomes [3]. Interestingly, recent reports have documented HR-
like activity of non-mitotic human somatic cells in G0 [50,51]. As that
activity required the participating DNA to be transcribed, such a mech-
anism may be possible at the active rDNA units.
As rDNA instability may have serious adverse consequence for the
cell including induction of the DDR, HR of rDNA is under tight control
[15,26,30]. For instance, in yeast, the critical component of the HR
machinery, Rad52 is generally excluded from the nucleolus where the
rDNA is located [52]. In addition, rDNA double strand breaks associate
with Rad52 only after a transient exit of the affected rDNA region
from the nucleolus. These restrictions ensure rDNA stability and are at
least in part mediated by sumoylation of Rad52. Interestingly, in
mouse G0 and S cells Rad52 is enriched in the nucleolus suggesting it
may also participate in HR of rDNA in mammals [53]. While mediators
of HR such as Rad52 appear to have a restricted access and/or activity
at rDNA, anti-recombinogenic regulators have been found in proximity
of rDNA including yeast DNA helicase Srs2 [52]. Such an anti-
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remarkable destabilization has been reported in cell lines from patients
with the defective human DNA helicase BLM [25]. Like Srs2, BLM
inhibits HR. While most components of the HR machinery are not
expressed in normal mature mammalian brain (http://www.brain-
map.org/), there are no data on the activity of these components in
neurodegeneration. However, our results indicate that at least in AD
and DLB such a pathway may become re-activated. This conclusion is
in agreement with the reported expansion of telomeres in the AD
hippocampus as HR is presumed to be a major positive regulator of
telomere length in most if not all somatic cells where telomerase is
not expressed [4,43,44].
Rates of HR in rDNAmay be affected by changes in chromatin struc-
ture and Pol1 activity. For instance, loss of rDNA–condensin interactions
or reduced repressive chromatin modiﬁcations including DNA and
histone methylation as well as histone de-acetylation increase rDNA
recombination and reduce its stability in yeast, ﬂy and murine cells
[54,55,31,56,57]. In yeast, loss of Pol1 activity due to deletions of its crit-
ical subunits or associated co-factors promotes rDNA instability [58,59].
Such effects may be due to structural disruption of the nucleolus in re-
sponse to Pol1 inhibition and subsequent changes to rDNA chromatin.
Thus, in the neurodegeneration-affected human brain tissue, altered
epigenetic status of rDNA and/or changes to Pol1 activity may also con-
tribute to increased recombination of rDNA.
HR including that of rDNA is initiated by DNA damage [15,30,44].
DNA double strand breaks that are the major recombinogenic form of
DNA damage have been recently reported in normal mouse forebrain
neurons following periods of increased physiological neuronal activity[60]. Moreover, their repair appeared to be impaired in a mouse
model of AD-like amyloidosis. Evidence for double strand break-
associated phosphorylation of the histone variant H2AX has also been
found in astrocytes fromADbrain [61]. In addition, HRmay be activated
by bulkyDNA adducts and single strandDNA gaps that are generated by
the adduct removal via the nucleotide excision repair [44,62]. Oxidative
DNAdamage iswell documented in both AD andDLB [40,63] and oxida-
tive bulky DNA adducts have been observed in the brain [64]. Hence, in
the degenerating brain, HR and the subsequent destabilization of rDNA
may be a result of excessive DNA damage.
At this stage one can only speculate about possible consequences of
rDNA destabilization in human cells including those in the brain. The
reported changes in rDNA content are unlikely to affect ribosomal
biogenesis as only a fraction of rDNA units is required for efﬁcient
ribosome supply even during accelerated growth in development
[65,66]. Conversely, in the ﬂy, the heterochromatin content appeared
to be directly inﬂuenced by the number of rDNA copies independent
of ribosomal biogenesis suggesting that rDNA instability may affect
heterochromatin maintenance in mammalian cells [11]. In support of
such a notion, in a mouse cell line, loss of heterochromatin coincided
with loss of rDNA [31]. This occurred in response to a deﬁciency in
rDNA silencing by the nucleolar repressive complex (NoRC) [31].
These observations indicate that the silenced, inactive copies of rDNA
play an important role in maintenance of the heterochromatin. In
turn, the rDNA-linked changes in heterochromatin content could affect
expression of nearby genes and alter global genomic stability [67].
Finally, structural and functional connections between the heterochro-
matin and rDNA are suggested by physical interactions between these
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heterochromatin formation [68,69].
Interestingly, ﬂies with variation in rDNA copy number also have
functional changes to their euchromatin including relatively small but
widespread effects on gene expression [70]. Such changes were not
only observed in the engineered mutants of rDNA but were also found
in ﬂies with natural variation in rDNA copy number. Interestingly,
genes involved in mitochondrial function and lipid metabolism were
particularly affected by rDNA copy number. Such effects would ﬁt well
with the AD- and DLB-associated dysfunction of the mitochondria
and/or dysregulation of brain lipid homeostasis [71–74].
Last but not least, yeast studies led to a proposition that the inactive
copies of rDNA sequester mediators of the cytotoxic DDR pathway
[13,26]. Hence, loss of rDNA copies could result in activation of such a
pathway. Conversely, expansion of rDNA could increase its activation
threshold making cells more resistant to DNA damage. In support of
this possibility, yeast sensitivity to a genotoxic chemical, methyl
methanesulfonate (MMS) was inversely proportional to the genomic
rDNA content [13]. Of note, in mammalian cells, stress-induced seques-
tration of various proteins has been demonstrated by the rRNA non-
coding regions of rDNA [14]. Therefore, changes in rDNA copy number
may affect cellular stress response including that to DNA damage.
To ﬁrmly establish and characterize the association of rDNA instabil-
ity with neurodegeneration, our ﬁndings should be repeated on bigger
cohorts of control, DLB, and AD individuals and sample more brain
regions and non-neuronal tissues. Presence of rDNA instability in
other neurodegenerative diseases should also be examined. As rDNA
instability is documented not only in neurodegeneration but also in can-
cer, identifying its causes and consequences deserves attention from the
research community. In the meantime, a working model can be pro-
posed where the apparent instability of rDNA in the degenerating
brain is a result of DNAdamage-inducedHR (Fig. 7). The alterednumber
of rDNA copies would then affect genomic heterochromatin levels,
expression of euchromatin-located genes and/or the DDR. If the rDNA
content increases, heterochromatin levels go up, the rDNA inﬂuence
over expressed genes is stronger and DDR resistance is higher (Fig. 7).
The opposite may be true if rDNA content declines (Fig. 7). Thus the ob-
served increases of rDNA in the degeneration-affected cerebral cortex
may contribute to compensation for the cellular damage/distress and
promote cell survival. Such an effect could explain the apparent discrep-
ancy between the cerebellar and the cerebro-cortical rDNA content in
DLB. Namely, as in DLB, the cerebellum has no obvious pathology/cell
loss, there would be no selection factor against “inferior” genomic ar-
rangements and the major end result of rDNA instability will be overall
reduction of rDNA content. Conversely, in the cortex, cell death would
produce enrichment of the resistant cells with expanded rDNA.
Likewise, one could speculate that rDNA copy number variability may
be an important factor increasing the ability of cancer cells to adapt to
changes in cellular environment including therapy resistance.
In summary,we did notﬁndany indication for brain rDNA instability
in aging. Conversely, we have obtained an initial evidence of DLB-
associated rDNA instability in the brain including an apparent rDNA
expansion in the neurodegeneration-affected cerebral cortex. While
these ﬁndings raise many questions on the origin and the role of rDNA
instability in aging-associated neurodegenerative diseases, they also
suggest that HR may become activated in these conditions. Hence, the
reported rDNA instability may be a component of a wider shift towards
genomic disorganization with hyper-recombination of homologous
sequences being one of its causes.
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